This key industry gathering provided a valuable opportunity for our teams to connect with partners, customers, and key stakeholders from across the Asian eyecare and skincare ecosystems. These discussions enabled us to share insights, explore emerging trends, and identify new collaboration opportunities.
PCHi offers a unique platform to address innovation and the evolving needs of next-generation formulations. On this occasion, HTL Biotechnology showcased its expertise in high-quality biopolymers, supporting innovation in both healthcare and personal care applications.
We would like to thank everyone we met during the event for the quality of the exchanges and their interest in our solutions.
From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
A time of renewal, ambition, and fresh opportunities for growth.
HTL Biotechnology took part in IMCAS 2026, one of the leading international congresses dedicated to aesthetic medicine and dermatology. This major event was an opportunity to highlight the company’s strategy, innovations, and commitment to advancing regenerative medicine through high-performance biopolymers.
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.